ASX/PAROB (ASX/PAROB)

Australian Securities Exchange: ASX/PAROB · AUD

A$0.14

-0.01 (-3.4%)· Recorded snapshot

Market cap	153.5M
Net income (ttm)	-56.3M
EPS (ttm)	-A$0.15
Volume	215,676

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -56.3M
EPS (ttm): -A$0.15
Market cap: 153.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-457

P25 n/aP50 n/aP75 n/a

ROIC-237.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.6%

Nasdaq Composite-2.3%

Dow Jones Industrial Average+1.9%

Russell 2000+1.8%

All ASX/PAROB indicators

Market & fundamental data

Available fields

123

Groups with data

Currency

AUD

Showing 123 of 123 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-26
Enterprise value	AUD 145.5M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-09-04
Fiscal year end	June
Founded	2014
Industry	Biotechnology
Is primary listing	No
ISIN number	AU0000475006
Last refreshed	2026-10-29
Market cap	AUD 153.5M
Next earnings date	2026-11-26
Price	AUD 0.14
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-09-18
Symbol	asx/PAROB
Website	https://www.paradigmbiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-108.74%
FCF / EV yield	-30.02%
FCF yield	-28.46%
Industry forward P/E	28.51x
P/B ratio	44.22x
Price / tangible book value	59.84x
Sector forward P/E	33.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-138.75%
ROA (5Y)	-77.43%
ROCE	-1,540.56%
ROE	-456.96%
ROE (5Y)	-172.31%
ROIC	-237.77%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth quarters	2
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	AUD 150,388
EBIT	AUD -61.2M
EBITDA	AUD -61M
EPS	AUD -0.15
Financing cash flow	AUD 43.7M
Free cash flow	AUD -43.7M
Free cash flow minus SBC	AUD -45.4M
Gross profit	AUD -12,128
Investing cash flow	AUD -552,317
Net borrowing	AUD 23M
Net cash flow	AUD -1.4M
Net income	AUD -56.3M
Operating cash flow minus SBC	AUD -45.4M
Operating income	AUD -61.2M
Stock-based compensation	AUD 1.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	AUD 0.01
Debt / equity	2.16
Interest coverage	-24.87
Long-term assets	AUD 1.4M
Long-term liabilities	AUD 501,290
Net cash (debt)	AUD 7.9M
Net cash / market cap	5.17%
Net cash growth	-52.8%
Net debt / equity	-2.29
Piotroski F-Score	1
Property, plant and equipment	AUD 499,103
Shareholders' equity	AUD 3.5M
Tangible book value	AUD 2.6M
Tangible book value per share	AUD 0.00
Total assets	AUD 30.6M
Total cash	AUD 15.4M
Total debt	AUD 7.5M
Total liabilities	AUD 27.1M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	AUD 29.1M
Current liabilities	AUD 26.6M
Current ratio	1.1
Net working capital	AUD -5.7M
Quick ratio	1.07
Working capital	AUD 2.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-17.66%
Shareholder yield	-17.66%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	-3.45%
1M price change	75%
1M total return	75%
20-day SMA	AUD 0.12
50-day SMA	AUD 0.09
52-week high	AUD 0.15
52-week high date	2026-09-18
52-week low	AUD 0.03
52-week low date	2026-06-18
All-time high	AUD 0.15
All-time high date	2026-09-04
All-time low	AUD 0.03
All-time low date	2026-06-18
Average true range (ATR)	AUD 0.01
Average volume	385.2K
Change from 52-week high	-3.45%
Change from 52-week low	366.67%
Change from all-time high	-3.45%
Change from all-time low	366.67%
Change from open	0%
Day's gap	-3.45%
Dollar volume	AUD 30,195
High price	AUD 0.15
Low price	AUD 0.14
Monthly RSI	0
Open price	AUD 0.14
Position in 52-week range	0%
Previous close	AUD 0.15
Price vs 20-day SMA	15.51%
Price vs 50-day SMA	47.99%
Relative volume	0.56
RSI	63.99
Sharpe ratio	3.77
Sortino ratio	7.49
Volume	215.7K
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	553.9M
Shares change (QoQ)	-21.17%
Shares change (YoY)	17.66%
Shares held by insiders	11.17%
Shares held by institutions	6.26%

Deeper analysis on ASX/PAROB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this ASX/PAROB report

Is a complete ASX/PAROB research report available?

No complete published report is available for asx/PAROB (ASX/PAROB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

153.5M

Net income (ttm)

-56.3M

EPS (ttm)

-A$0.15

Volume

215,676

Metric

Value

Amount currency

AUD

Country

Australia

Country code

Earnings date

2026-11-26

Enterprise value

AUD 145.5M

Exchange

Australian Securities Exchange

Financial currency

AUD

Financial report date

2026-06-30

First seen

2026-09-04

Fiscal year end

June

Founded

2014

Industry

Biotechnology

Is primary listing

ISIN number

AU0000475006

Last refreshed

2026-10-29

Market cap

AUD 153.5M

Next earnings date

2026-11-26

Price

AUD 0.14

Price currency

AUD

Sector

Healthcare

SIC code

2836

Stock price date

2026-09-18

Symbol

asx/PAROB

Website

https://www.paradigmbiopharma.com

Metric

Value

Earnings yield

-108.74%

FCF / EV yield

-30.02%

FCF yield

-28.46%

Industry forward P/E

28.51x

P/B ratio

44.22x

Price / tangible book value

59.84x

Sector forward P/E

33.91x

Metric

Value

ROA

-138.75%

ROA (5Y)

-77.43%

ROCE

-1,540.56%

ROE

-456.96%

ROE (5Y)

-172.31%

ROIC

-237.77%

Metric

Value

EPS growth years

Net income growth years

Revenue growth quarters

Revenue growth years

Metric

Value

Depreciation and amortization

AUD 150,388

EBIT

AUD -61.2M

EBITDA

AUD -61M

EPS

AUD -0.15

Financing cash flow

AUD 43.7M

Free cash flow

AUD -43.7M

Free cash flow minus SBC

AUD -45.4M

Gross profit

AUD -12,128

Investing cash flow

AUD -552,317

Net borrowing

AUD 23M

Net cash flow

AUD -1.4M

Net income

AUD -56.3M

Operating cash flow minus SBC

AUD -45.4M

Operating income

AUD -61.2M

Stock-based compensation

AUD 1.7M

Metric

Value

Book value per share

AUD 0.01

Debt / equity

2.16

Interest coverage

-24.87

Long-term assets

AUD 1.4M

Long-term liabilities

AUD 501,290

Net cash (debt)

AUD 7.9M

Net cash / market cap

5.17%

Net cash growth

-52.8%

Net debt / equity

-2.29

Piotroski F-Score

Property, plant and equipment

AUD 499,103

Shareholders' equity

AUD 3.5M

Tangible book value

AUD 2.6M

Tangible book value per share

AUD 0.00

Total assets

AUD 30.6M

Total cash

AUD 15.4M

Total debt

AUD 7.5M

Total liabilities

AUD 27.1M

Metric

Value

Current assets

AUD 29.1M

Current liabilities

AUD 26.6M

Current ratio

1.1

Net working capital

AUD -5.7M

Quick ratio

1.07

Working capital

AUD 2.6M

Metric

Value

Buyback yield / dilution

-17.66%

Shareholder yield

-17.66%

Metric

Value

1D price change

-3.45%

1M price change

75%

1M total return

75%

20-day SMA

AUD 0.12

50-day SMA

AUD 0.09

52-week high

AUD 0.15

52-week high date

2026-09-18

52-week low

AUD 0.03

52-week low date

2026-06-18

All-time high

AUD 0.15

All-time high date

2026-09-04

All-time low

AUD 0.03

All-time low date

2026-06-18

Average true range (ATR)

AUD 0.01

Average volume

385.2K

Change from 52-week high

-3.45%

Change from 52-week low

366.67%

Change from all-time high

-3.45%

Change from all-time low

366.67%

Change from open

Day's gap

-3.45%

Dollar volume

AUD 30,195

High price

AUD 0.15

Low price

AUD 0.14

Monthly RSI

Open price

AUD 0.14

Position in 52-week range

Previous close

AUD 0.15

Price vs 20-day SMA

15.51%

Price vs 50-day SMA

47.99%

Relative volume

0.56

RSI

63.99

Sharpe ratio

3.77

Sortino ratio

7.49

Volume

215.7K

Weekly RSI

Metric

Value

Float

553.9M

Shares change (QoQ)

-21.17%

Shares change (YoY)

17.66%

Shares held by insiders

11.17%

Shares held by institutions

6.26%

ASX/PAROB (ASX/PAROB)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/PAROB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/PAROB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/PAROB

Frequently asked questions

ASX/PAROB (ASX/PAROB)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/PAROB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/PAROB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/PAROB

Frequently asked questions